Ebers Pharmaceuticals Ltd


BSE: 507715 | NSE: NA | ISIN: INE669D01018 
Market Cap: [Rs.Cr.] 1 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Formulations

 Discuss this stock

Director's Report

EBERS PHARMACEUTICALS LIMITED ANNUAL REPORT 2000-2001 DIRECTOR'S REPORT To the Members of Ebers Pharmaceuticals Limited Your Directors present the Twenty Second Annual Report of the Company together with the Audited Statement of Accounts for the year ended 31st March, 2001. OPERATIONS During the year, the Company achieved total income of Rs. 0 77 Lacs compared to loss of 3.48 lacs in Previous Year which is a indication of small improvement compare to Previous Year Since the Global financial conditions are still not improved the Exports and Local Market is heavily affected but Company is still trying and hopeful for better working in Current Year. DIRECTORS Mr Ashok Raval retires by rotation and being eligible, offers himself for re-appointment. Mr. Anuj Kumar Rathi and Mr. R. Goppu resigned from directorship with effect from 28.08 2001. The Board wish to place on record their sincere appreciation for guidance provided by them. AUDITORS M/s. J. D. Padwal & Co., Chartered Accountants retire at the ensuing Annual General Meeting and being eligible offers themselves for re-appointment. AUDITORS REPORT Pursuant to the provisions of Section 217(3) of the Companies Act, 1956 the explanations in respect of the observation made in the Auditors Report are as under: i) The management is making all efforts and is hopeful of recoveries and therefore no provision for doubtful debts have been made in respect of Sundry debtors and advances of Rs. 60.60 Lacs. ii) Suitable special resolutions pursuant to the requirement of Section 372A are proposed for the approval of the members of the Company at the ensuing Annual General Meeting. iii) Other observation made are self explanatory. PARTICULARS OF EMPLOYEES There are no employees whose particulars are required to be given under Section 217(2A) of the Companies Act, 1956 read with the Companies (Particulars of Employees) Rules, 1975. CONSERVATION OF ENERGY,TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNING AND OUTGO Information required to be given pursuant to Section 217(1)(e) read with Companies (Disclosure of Particulars in the report of the Board of Directors) Rules, 1988 are given in Annexure annexed to this report. ACKNOWLEDGEMENT Your Directors wish to place on record their appreciation and acknowledge with gratitude, the support and co-operation extended to the Company by the employees at all level, Bankers, the Central and State Governments and the Shareholders. For and on behalf of the Board of Directors S. M. PARANDE (Managing Director) Mumbai : 30.08.2001
No Data

Related News

 
No Related News

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Ajanta Pharma 5,430.86 25.33 10.13 9.97 49.5 55.6 0.28
Sharon Bio-Med. 715.63 10.64 3.79 8.13 24.2 13.8 2.64
Kappac Pharma 658.16 0.00 21.71 0.00 0.0 0.0 0.06
Caplin Point Lab 513.06 25.28 12.77 2.62 40.6 53.9 0.16
Bliss GVS Pharma 478.38 8.87 1.52 2.75 24.2 40.6 0.17
Mahavir Advanced 398.00 0.00 45.26 0.00 0.0 0.0 0.00
Syncom Formul. 391.91 41.83 4.08 14.09 6.6 9.8 0.05
Ahlcon Parent(I) 357.34 18.32 4.86 10.50 26.9 31.2 0.41
Venus Remedies 314.77 5.16 0.68 4.21 16.1 14.4 0.69
Amrutanjan Healt 267.47 18.41 2.76 7.12 14.4 19.8 0.20
Arvind Remedies 220.39 3.74 0.84 4.80 25.2 20.1 2.73
Plethico Pharma. 170.01 6.51 0.32 35.79 -5.0 1.6 1.56
Hester Bios 156.71 15.54 2.06 5.68 15.2 21.7 0.32
Bharat Immunolog 155.88 17.52 3.69 1.11 11.6 18.5 0.12
Albert David 105.78 8.74 1.17 2.96 14.7 16.4 0.47

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

A K Rathi , Chairman 

S M Parande , Managing Director 

R Goppu , Director 

Ashok B Raval , Director 


Company Head Office / Quarters:
103 Shreepal Complex Suren Rd,
Andheri (E),
Mumbai,
Maharashtra-400093
Phone : 91-22-8367527
Fax : 91-22-8218340
E-mail :
Web : http://
Registrars:
Bigshare Services Pvt Ltd
E-2/3 Ansa Indl Est
Saki Vihar Road
Sakinaka Andheri(E)
Mumbai - 400072

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Jul-2014
M T W T F S S
21 22 23 24 25 26 27
IPO
listIssue Open : Bhanderi Infra.
Economic Events
list Adjusted Merchandise Trade Balance (Yen)
list Merchandise Trade Balance Total (Yen)
Results
list Britannia Inds. | Coromandel Inter | Coromandel Inter | A B B